• News
  • SAN DIEGO
  • Finance

Dexcom gains FDA approval; stocks rise

Share prices in San Diego's Dexcom Inc. rose nearly 6 percent in after-hours trading Tuesday after the company announced it had received FDA approval for a new system aimed at providing diabetic patients and their doctors with real-time information about their sugar levels.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Dexcom Inc.

Company Website

5555 Oberlin Drive
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
DXCM
44.08
  0.54  
+ 1.24%
686,798,000
49.83
25.49

Insider Trade Data

Date Insider Shares Type Value
08/19/2014 Doubleday, Richard B 20,000 Exchange $196,000
08/19/2014 Gregg, Terrance H 226,107 Exchange $1,510,137
08/19/2014 Doubleday, Richard B 20,000 Sell $900,278
08/19/2014 Gregg, Terrance H 236,107 Sell $10,462,626
08/18/2014 Roper, Jess 8,000 Sell $351,628

Dexcom Inc. Executive(s):

Terrance Gregg

  • Chief Executive Officer, Director

Kevin Sayer

  • Director, President

Patrick Murphy

  • Assist. General Counsel

Similar Companies

NAICS - -
Subscribe Today!